Company Analysis Sinopharm Group Co., Ltd.
1. Summary
Advantages
- Price (11.82 $) is less than fair price (20.13 $)
- Dividends (5.76%) are higher than the sector average (1.53%).
- The stock's return over the last year (-9.35%) is higher than the sector average (-10.48%).
- Current debt level 18.35% is below 100% and has decreased over 5 years from 19.28%.
Disadvantages
- The company's current efficiency (ROE=12.14%) is lower than the sector average (ROE=13.38%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Sinopharm Group Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -6.9% | -10.9% | -1.2% |
| 90 days | -16.8% | -6.4% | -6.6% |
| 1 year | -9.4% | -10.5% | 6.9% |
SHTDY vs Sector: Sinopharm Group Co., Ltd. has outperformed the "Healthcare" sector by 1.13% over the past year.
SHTDY vs Market: Sinopharm Group Co., Ltd. has significantly underperformed the market by -16.26% over the past year.
Stable price: SHTDY is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SHTDY with weekly volatility of -0.1798% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (11.82 $) is lower than the fair price (20.13 $).
Price significantly below the fair price: The current price (11.82 $) is 70.3% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (6.02) is lower than that of the sector as a whole (31.32).
P/E vs Market: The company's P/E (6.02) is lower than that of the market as a whole (53.25).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.4527) is lower than that of the sector as a whole (3.11).
P/BV vs Market: The company's P/BV (0.4527) is higher than that of the market as a whole (-8.35).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.0913) is lower than that of the sector as a whole (3.24).
P/S vs Market: The company's P/S indicator (0.0913) is lower than that of the market as a whole (4.72).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (2.27) is lower than that of the sector as a whole (10.15).
EV/Ebitda vs Market: The company's EV/Ebitda (2.27) is lower than that of the market as a whole (28.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 5.19% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (5.19%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-27.73%).
5.4. ROE
ROE vs Sector: The company's ROE (12.14%) is lower than that of the sector as a whole (13.38%).
ROE vs Market: The company's ROE (12.14%) is higher than that of the market as a whole (4.9%).
5.5. ROA
ROA vs Sector: The company's ROA (2.36%) is lower than that of the sector as a whole (6.22%).
ROA vs Market: The company's ROA (2.36%) is lower than that of the market as a whole (16.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (8.01%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (8.01%) is lower than that of the market as a whole (11.06%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 5.76% is higher than the average for the sector '1.53%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.76% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 5.76% has been growing weakly or stagnant over the past 5 years. Growth over only 3 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (28.26%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
